Biomarin pharmaceutical articles
-
Growth opportunities for Imexpharm in Vietnamese pharmaceutical market
IMP is accelerating its investment strategy, anticipating high-value medicinal products in response to the increasing demand of domestic and foreign markets
-
Cowspiracy Co-Director Makes New Film Announcement About Pharmaceuticals
A new documentary is poised to shake up the conversation surrounding pharmaceutical testing in the United States.
-
ACADIA Pharmaceuticals (ACAD) – Research Analysts’ Recent Ratings Updates
A number of firms have modified their ratings and price targets on shares of ACADIA Pharmaceuticals (NASDAQ: ACAD) recently: 5/10/2024 – ACADIA Pharmaceuticals had its price target lowered by analysts at Bank of America Co. from $26.00 to $22.00. They now have a “neutral” rating on the stock. 5/9/2024 – ACADIA Pharmaceuticals had its “overweight” […]